Showing results (311-320 of 366) with videos related to
Sort By:
Pageof 37
Journal of Medicinal Chemistry|December 25, 1992
Analogues of platelet activating factor. 7. Bis-aryl amide and bis-aryl urea receptor antagonists of PAFA Wissner, M L Carroll, B D Johnson, et al.ACS Medicinal Chemistry Letters|October 22, 2021
Potent Anti-Inflammatory, Arylpyrazole-Based Glucocorticoid Receptor Agonists That Do Not Impair Insulin SecretionBrandon J Kennedy, Ashley M Lato, Alexander R Fisch, et al.International Journal of Radiation Oncology, Biology, Physics|June 20, 2022
Two-Year Tumor Outcomes of a Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Owing to Concurrent Radiation Therapy and Cisplatin for Head and Neck CancerCarryn M Anderson, Christopher M Lee, Deborah Saunders, et al.Journal of the American College of Cardiology|November 13, 2007
Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM ProgramAkshay S Desai, Karl Swedberg, John J V McMurray, et al.Journal of Medicinal Chemistry|September 17, 1993
Preparation of substituted N-phenyl-4-aryl-2-pyrimidinamines as mediator release inhibitorsR Paul, W A Hallett, J W Hanifin, et al.Circulation. Cardiovascular Quality and Outcomes|August 1, 2013
Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF)Jonathan G Howlett, Justin A Ezekowitz, Mohua Podder, et al.European Journal of Heart Failure|April 27, 2010
Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity (CHARM) programmeSu Min Chang, Christopher B Granger, Peter A Johansson, et al.Journal of Medicinal Chemistry|November 1, 1985
Imidazo[1,5-d][1,2,4]triazines as potential antiasthma agentsR Paul, J A Brockman, W A Hallett, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|March 10, 2019
The Power of Resolution: Contextualized Understanding of Biological Responses to Liver Injury Chemicals Using High-throughput Transcriptomics and Benchmark Concentration ModelingSreenivasa C Ramaiahgari, Scott S Auerbach, Trey O Saddler, et al.European Journal of Heart Failure|June 1, 2005
Patient perception of the effect of treatment with candesartan in heart failure. Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programmeEileen O'Meara, Eldrin Lewis, Chris Granger, et al.Pageof 37